FDA 483 - Lawrence M. Lehrner MD - October 14, 2020

Lawrence M. Lehner MD, a clinical investigator in Las Vegas, NV, was cited for significant deviations from a study protocol during an FDA inspection. The firm failed to timely report serious adverse events for multiple subjects and administered incorrect doses of randomized treatment. These issues indicate a serious lack of adherence to clinical trial regulations and investigator responsibilities.